Remove the prohibition on using appropriated funds for supervised drug consumption facilities.

Madeleine Dean · Pennsylvania · Democratic

policy impact 0.58 specificity 0.82 extraction confidence 93%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

On page 187, line 13-18, strike the following language: “Provided further, That none of the funds appropriated in this Act may be used for the operation of a supervised drug consumption facility that permits the consumption onsite of any substance listed in schedule I of section 202 of the Controlled Substances Act (21 U.S.C. 812)"

Dean seeks to strike the appropriations rider banning funding for supervised drug consumption facilities.

DD11A4F9C93D43C8B98AAEB3805329381D4D992A2228B805A0A78D841F8BC4CE.lhhs-fy26-dean-amendments-.pdf
secondary · other · model gpt-5.4-mini

Evidence

legacy_unverified · Source version not recorded · locator unknown

Sec. 525 restricts funds for sterile needles or syringes and then moves directly to Sec. 526; the public-law text contains no supervised-consumption-facility funding prohibition.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The enacted FY2026 Labor-HHS-Education appropriations division removed the prior rider barring appropriated funds for supervised drug consumption facilities. That makes the commitment delivered for current FY2026 appropriations, through September 30, 2026.

delivered unknown

Public Law 119-75 - Consolidated Appropriations Act, 2026
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

GovInfo lists H.R. 9260 as reported in House on June 11, 2026; Sec. 525 would bar funds for operation of supervised drug consumption facilities involving Schedule I substances.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The most recent FY2027 House Labor-HHS-Education appropriations bill would restore the supervised-consumption-facility prohibition, but it was only reported and placed on the Union Calendar, not enacted. This leaves the FY2027 continuation of the current delivery unresolved and at risk of reversal.

unresolved unknown

H.R. 9260 (RH) - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
secondary · model gpt-5.5 · confidence 82%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): delivered. same_term

Delivered. Rep. Madeleine Dean was in federal office and on the House LHHS Appropriations Subcommittee when she filed a FY2026 amendment specifically striking the prohibition on federal funding for supervised drug consumption facilities. The enacted Consolidated Appropriations Act, 2026, Public Law 119-75, approved February 3, 2026, omitted that rider from Sec. 525, leaving only the sterile needle/syringe restriction. The FY2027 House-reported H.R. 9260 would restore the prohibition, but it had not been enacted; current enacted law still satisfies the promise. Sources checked include https://dean.house.gov/2025/9/congresswoman-dean-files-amendments-to-restore-mental-health-education-and-research-funding and https://www.govinfo.gov/content/pkg/PLAW-119publ75/html/PLAW-119publ75.htm.

provider codex_cli · model gpt-5.5 · confidence 91%